Type III Mixed Cryoglobulinemia and Antiphospholipid Syndrome in a Patient With Partial DiGeorge Syndrome by Chang, Alice D. et al.
Type III mixed cryoglobulinemia and antiphospholipid syndrome
in a patient with partial DiGeorge syndrome
†
ALICED.CHANG
1,RAFFITACHDJIAN
1,KERRYGALLAGHER
1,DEBORAHK.MCCURDY
1,
CHARLES LASSMAN
2, E. RICHARD STIEHM
1, & ORAYADIN
3
1Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Mattel Children’s Hospital, University of
California, Los Angeles, CA, USA,
2Department of Pathology and Laboratory Medicine, Center for the Health Sciences,
University of California, Los Angeles, CA, USA, and
3Division of Nephrology, Department of Pediatrics, Mattel Children’s
Hospital, University of California, Los Angeles, CA, USA
Abstract
We studied a 14 year-old boy with partial DiGeorge syndrome (DGS), status post complete repair of Tetralogy of Fallot, who
developed antiphospholipid syndrome (APS) and type III mixed cryoglobulinemia. He presented with recurrent fever and
dyspnea upon exertion secondary to right pulmonary embolus on chest computed tomography (CT). Coagulation studies
revealed homozygous methylene tetrahydrofolate reductase 677TT mutations, elevated cardiolipin IgM antibodies, and
elevated b2-glycoprotein I IgM antibodies. Infectious work-up revealed only positive anti-streptolysin O (ASO) and anti-
DNAse B titers. Autoimmune studies showed strongly positive anti-platelet IgM, elevated rheumatoid factor (RF), and
positive cryocrit. Renal biopsy for evaluation of proteinuria and hematuria showed diffuse proliferative glomerulonephritis
(DPGN) with membranoproliferative features consistent with cryoglobulinemia. Immunoﬁxation showed polyclonal bands.
Our patient was treated successfully with antibiotics, prednisone, and mycophenolate mofetil (MMF). This is the ﬁrst report
of a patient with partial DGS presenting with APS and type III mixed cryoglobulinemia possibly due to Streptococcal
infection.
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Introduction
DiGeorge syndrome (DGS), ﬁrst described by Dr
Angelo DiGeorge in 1965 (Cooper et al. 1965), now
known as the 22q11 deletion syndrome, is associated
with craniofacial, cardiac, thymic, immunologic,
endocrine, and developmental abnormalities (Perez
and Sullivan 2002). Approximately 9–30% of
patients with DGS have autoimmune diseases
(Jawad et al. 2001; Gennery et al. 2002). Here we
describe a patient with DGS who developed
cryoglobulinemia and antiphospholipid syndrome
(APS).
Case presentation
A 14 year old Hispanic male with partial DGS
presented with recurrent fevers, fatigue, and dyspnea.
He had a history of Tetralogy of Fallot, fully repaired
at 18 months of age, and a bovine pulmonic valve
placement at 8 years of age. Absence of the thymus
was noted at the initial surgery. The cardiac history,
absent thymus, and 22q11.2 microdeletion led to the
diagnosis of DGS. Immunologic evaluation at 18
months of age showed protective titers to Haemophilus
inﬂuenzae and Diphtheria, normal lymphocyte subsets,
lymphocyte proliferation to Candida but not Tetanus,
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consistent with partial DGS.
Two months prior to presentation, the patient
developed recurrent high fevers, exertional dyspnea,
bilateral shin pain, and severe fatigue. Admission
temperature was 398C, with stable vital signs and
without respiratory distress on room air. Chest
exam revealed clear breath sounds bilaterally, right
axillary line tenderness to palpation, and a grade V
holosystolic murmur. Routine laboratory evaluation
showed a white blood cell count of 5 £ 10
3/ml,
hemoglobin of 9.1g/dl, platelet count of 96 £ 10
3/ml,
and sedimentation rate of 32mm/h (normal ,10).
Electrolyte analysis and liver function studies were
normal. Urine analysis showed microscopic hematuria
(.180 red blood cells/high power ﬁeld) with 1 þ
proteinuria. Chest X-ray showed right lower lobe
pneumonia. Chest computed tomography (CT)
showed a 1cm calciﬁed pulmonary embolus in the
right branch pulmonary artery with posterior right
lower lobe bronchograms. Sinus CT showed pan-
sinusitis. Abdominal CT, renal ultrasound, and bone
scan were normal. Echocardiogram showed a 65%
ejection fraction, mild to moderate pulmonic stenosis,
paradoxical septal motion, and absence of vegetations.
Studies for hepatitis A, B and C viruses, Human
immunodeﬁciency virus, Mycoplasma, Cytomegalo-
virus, Herpes simplex virus, Epstein Barr virus, and
Parvovirus B19 were negative. Anti-streptolysin O
(ASO) titers were 385IU/ml (normal ,150), and
anti-DNAse B titers were 1:340 (normal ,1:170).
Multiple blood and urine cultures were negative.
Rheumatoid factor (RF) was 143IU/ml (normal
,25). Anti-platelet IgM was strongly positive. Double
stranded DNA (DsDNA) was 261IU/ml (normal
,200) by enzyme immunosorbent assay, but was
negative by indirect immunoﬂuorescence. Antibody
titers for Smith, ribonuclear protein (RNP), Sjogren’s
A and B (SSA, SSB), scleroderma (Scl-70), and anti-
neutrophil cytoplasmic antibody (ANCA) were
negative. C3 was 85mg/dl (normal 71–141); C4 was
8mg/dl (range 12–34). C1Q complexes were 136mg
Eq/ml (normal ,2.0); CH50 was 38 CAE (normal
60–144). The CD3 cells were 802/cmm (normal
for age: 1400–2000); CD4 cells were 333/cmm
(range 700–1100); CD8 cells were 406/cmm (range
600–900); CD19 cells were 81/cmm (range 300–
500). IgG levels were 2190mg/dl (normal for age:
822–1066), IgA 191mg/dl (range 85–211), and IgM
228mg/dl (range 39–59). Serum and urine immuno-
ﬁxation lacked monoclonal bands. Cryocrit was 1%
on day 1 (normal: negative on day 4).
Coagulation studies revealed normal thromboplastin
and prothrombin times. Dilute Russell viper venom
time (DRVVT) was borderline positive; cardiolipin
IgM was 17 PLU (normal ,10); b2-glycoprotein I
(b2GPI)IgMwas36U/ml(normal,10).Homozygous
methylene tetrahydrofolate reductase (MTHFR)
677TT mutations were present with a normal homo-
cysteine level of 5mmol/l (normal 5–15).
A bone marrow biopsy ruled out malignancy;
bacterial, fungal, viral and mycobacterial studies of
the marrow were negative. Renal biopsy for evaluation
of hematuria and proteinuria (1019mg/24h) demon-
strated diffuse proliferative glomerulonephritis
(DPGN) with features of membranoproliferative
glomerulonephritis (MPGN) compatible with cryo-
globulinemic glomerulonephritis (Figure 1).
The patient received cefotaxime, azithromycin,
heparin followed by warfarin, and prednisone at a dose
of 1mg/kg divided three times daily; within 2 days of
prednisone,ourpatientdefervescedfortheﬁrsttimein3
months. The triad of purpura, weakness, and arthralgia
never occurred. The cryocrit resolved within 1 month
of prednisone therapy; proteinuria resolved within 2
months. After transient improvement, his fatigue
progressed despite treatment with 1g/day of mycophe-
nolate mofetil (MMF). This resolved completely after
successful valvuloplasty for pulmonic stenosis and left
pulmonary artery (LPA) stent placement for previously
undiagnosed stenosis. After 8 months, patient’s ACL
IgM was 13 PLU, DRVVTwas borderline positive, but
b2GPI IgM became negative.
In summary, this is a 14 year-old boy with partial
DGS who developed APS, type III mixed cryoglobu-
linemia with DPGN, immune thrombocytopenia,
MTHFR 677TT mutations, and pulmonic valve and
LPA stenosis.
Discussion
Up to 30% of patients with DGS have associated
autoimmune disease (Jawad et al. 2001; Genneryet al.
2002). These include Graves’ disease (Pong et al.
1985; Segni and Zimmerman 2002), juvenile poly-
articular rheumatoid arthritis (Sullivan et al. 1997;
Davies et al. 2001), Evans syndrome (Pinchas-Hamiel
et al. 1994; Kratz et al. 2003), autoimmune hemolytic
anemia (Davies et al. 2003), pancytopenia (Davies
et al. 2003; Bruno et al. 2002), vitiligo (Jawad et al.
2001), psoriasis (Jawad et al. 2001), vasculitis and
Raynaud’s (Gennery et al. 2002), and liver disease
(Kratz et al. 2003). In these patients, the associated
immunologic abnormalities included elevated or low
IgG levels, IgA deﬁciency, decreased T cell function
and proliferation, decreased B and T cell subsets. The
immunologic anomalies were not consistently associ-
ated with any speciﬁc autoimmune diagnosis (Pong
et al. 1985; Pinchas-Hamiel et al. 1994; Sullivan et al.
1997; Davies et al. 2001; Jawad et al. 2001; Bruno
et al. 2002; Gennery et al. 2002; Segni and Zimmer-
man 2002; Davies et al. 2003; Kratz et al. 2003).
Deﬁnitive mechanisms for autoimmunity in DGS
have not been elucidated to date. The leading theory
points to the lack of lymphocyte education and
deletion of autoreactive T cells in the thymus
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(Jawad et al. 2001), increased helper to suppressor T
cell ratio (Etzioni and Pollack 1994), and oligoclonal
T cell expansion (Markert et al. 2004) lead to immune
dysregulation and autoimmune phenomena.
Our patient had type III cryoglobulinemia and
secondary DPGN. Renal pathology due to mixed
cryoglobulinemia varies from focal or mesangial
proliferative glomerulonephritis to the predominant
type I MPGN (Beddhu et al. 2002). Type III
cryoglobulinemia can develop secondary to malig-
nancies, infections (especially Hepatitis B and C), and
connective tissue diseases such as APS (Hanly and
Smith 2000; Beddhu et al. 2002). Mixed cryoglobu-
linemia has been associated with Streptococcal
infections (Hodson et al. 1978), with RF demonstrat-
ing Streptococcal antigen cross-reactivity (Schroder
and Christensen 1988). In our patient, elevated ASO
and anti-DNase B titers may represent an antecedent
group A Streptococcus infection or a hypergammaglo-
bulinemic state. It is possible that a Streptococcal
infection may have triggered the development of
mixed cryoglobulinemia in our patient.
Nucera et al. (2006) reported a patient with DGS
who developed APS, thrombocytopenia, cutaneous
thrombotic vasculopathy, compound heterozygous
MTHFR C677T and A1298C mutations, hyperho-
mocysteinemia, and cerebral vasculitis. Quantitative
immunoglobulin titers and lymphocyte subsets were
normal but speciﬁc antibody titers and lymphocyte
proliferation studies were not reported. Interestingly,
our patient also developed APS and had homozygous
MTHFR C677T mutations. Thromboembolic risk
factors in our patient included stenotic bovine
pulmonic valve (Reul et al. 1985), anti-phospholipid
antibodies (aPL), and homozygous MTHFR
mutations (Haywood et al. 2005). He met both the
Sapporo and the newly revised international con-
sensus criteria for APS (Miyakis et al. 2006). Post-
infectious aPL production has been described in the
literature and may be transient (Shoenfeld et al.
2006). Shoenfeld et al. (2006) showed that mice
immunized with H. inﬂuenzae, Neisseria gonorrhea,
or Tetanus toxoid produced pathogenic anti-b2GPI
antibodies that induced thrombocytopenia and fetal
loss in healthy pregnant mice. Pathogenic aPL in our
patient may have been triggered by a Streptococcal
infection. The bovine valve and the MTHFR
mutations may have provided the “second hit” in the
“two hit” hypothesis, where the “second hit” over-
comes the threshold for thrombosis in the presence of
aPL (“ﬁrst hit”) (Shoenfeld et al. 2006).
Conclusion
Autoimmune disease in patients with DGS is relatively
common. Our patient and the patient described by
Nucera et al. (2006), demonstrate that DGS patients
may develop systemic autoimmune disease of signiﬁ-
cant severity. Given the evidence for the infectious
origins of aPL (Shoenfeld et al. 2006), recurrent
infections in DGS in the background of compromised
immunoregulation may predispose these patients to
develop severe autoimmune complications such as
APS and cryoglobulinemia. DGS patients are at high
risk of infections despite normal immunologic ﬁndings
(Jawad et al. 2001; Gennery et al. 2002). This is the
ﬁrst report of a patient with partial DGS and MTHFR
677TT mutations who presented with type III mixed
Figure 1. Renal biopsy. A. Jones’ methenamine silver stain showed DPGN involving 23 of 25 glomeruli obtained (2 were globally sclerotic),
increased cellularity, with prominent glomerular basement membrane (GBM) double contouring (arrow). Mild tubulointerstitial edema and
focal tubular atrophy and ﬁbrosiswere present.B. Electron microscopy revealed areas of GBM duplicationwith electron-dense subendothelial
deposits (arrow), and endothelial elevation with electron-lucent ﬂocculent material underneath. There is mild mesangial expansion, matrix
cellularity, and numerous electron-dense deposits in the paramesangial region. “Fingerprint” substructures within dense deposits and
tubuloreticular deposits (seen in systemic lupus erythematosus and HIV nephritis) were absent. Neither vasculitis nor intraluminal thrombi
were found. Immunoﬂuorescence (not shown) revealed IgG, IgM, IgA, C1q, C3, k, and l staining. This biopsy showing DPGN with features
of MPGN was consistent with cryoglobulinemia.
Type III mixed cryoglobulinemia and antiphospholipid syndrome in DiGeorge syndrome 263cryoglobulinemia and APS after evidence of Strepto-
coccal infection.
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